The association of the lipidomic profile with features of polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) affects up to 18% of reproductive-aged women with reproductive and metabolic complications. While lipidomics can identify associations between lipid species and metabolic diseases, no research has examined the association of lipid species with the pathophysiological...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of molecular endocrinology Ročník 59; číslo 1; s. 93
Hlavní autori: Moran, L J, Mundra, P A, Teede, H J, Meikle, P J
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England 01.07.2017
Predmet:
ISSN:1479-6813, 1479-6813
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Polycystic ovary syndrome (PCOS) affects up to 18% of reproductive-aged women with reproductive and metabolic complications. While lipidomics can identify associations between lipid species and metabolic diseases, no research has examined the association of lipid species with the pathophysiological features of PCOS. The aim of this study was to examine the lipidomic profile in women with and without PCOS. This study was a cross-sectional study in 156 age-matched pre-menopausal women (18-45 years, BMI >20 kg/m ;  = 92 with PCOS,  = 64 without PCOS). Outcomes included the association between the plasma lipidomic profile (325 lipid species (24 classes) using liquid chromatography mass spectrometry) and PCOS, adiposity, homeostasis assessment of insulin resistance (HOMA), sex hormone-binding globulin (SHBG) and free androgen index (FAI). There were no associations of the lipidomic profile with PCOS or testosterone. HOMA was positively associated with 2 classes (dihydroceramide and triacylglycerol), SHBG was inversely associated with 2 classes (diacylglycerol and triacylglycerol), FAI was positively associated with 8 classes (ceramide, phosphatidylcholine, lysophosphatidylcholine, phosphatidylethanolamine, lysophosphatidylethanolamine, phosphatidylinositol, diacylglycerol and triacylglycerol) and waist circumference was associated with 8 classes (4 positively (dihydroceramide, phosphatidylglycerol, diacylglycerol and triacylglycerol) and 4 inversely (trihexosylceramide, G ganglioside, alkenylphosphatidylcholine and alkylphosphatidylethanolamine)). The lipidomic profile was primarily related to central adiposity and FAI in women with or without PCOS. This supports prior findings that adiposity is a key driver of dyslipidaemia in PCOS and highlights the need for weight management through lifestyle interventions.
AbstractList Polycystic ovary syndrome (PCOS) affects up to 18% of reproductive-aged women with reproductive and metabolic complications. While lipidomics can identify associations between lipid species and metabolic diseases, no research has examined the association of lipid species with the pathophysiological features of PCOS. The aim of this study was to examine the lipidomic profile in women with and without PCOS. This study was a cross-sectional study in 156 age-matched pre-menopausal women (18-45 years, BMI >20 kg/m ;  = 92 with PCOS,  = 64 without PCOS). Outcomes included the association between the plasma lipidomic profile (325 lipid species (24 classes) using liquid chromatography mass spectrometry) and PCOS, adiposity, homeostasis assessment of insulin resistance (HOMA), sex hormone-binding globulin (SHBG) and free androgen index (FAI). There were no associations of the lipidomic profile with PCOS or testosterone. HOMA was positively associated with 2 classes (dihydroceramide and triacylglycerol), SHBG was inversely associated with 2 classes (diacylglycerol and triacylglycerol), FAI was positively associated with 8 classes (ceramide, phosphatidylcholine, lysophosphatidylcholine, phosphatidylethanolamine, lysophosphatidylethanolamine, phosphatidylinositol, diacylglycerol and triacylglycerol) and waist circumference was associated with 8 classes (4 positively (dihydroceramide, phosphatidylglycerol, diacylglycerol and triacylglycerol) and 4 inversely (trihexosylceramide, G ganglioside, alkenylphosphatidylcholine and alkylphosphatidylethanolamine)). The lipidomic profile was primarily related to central adiposity and FAI in women with or without PCOS. This supports prior findings that adiposity is a key driver of dyslipidaemia in PCOS and highlights the need for weight management through lifestyle interventions.
Polycystic ovary syndrome (PCOS) affects up to 18% of reproductive-aged women with reproductive and metabolic complications. While lipidomics can identify associations between lipid species and metabolic diseases, no research has examined the association of lipid species with the pathophysiological features of PCOS. The aim of this study was to examine the lipidomic profile in women with and without PCOS. This study was a cross-sectional study in 156 age-matched pre-menopausal women (18-45 years, BMI >20 kg/m2; n = 92 with PCOS, n = 64 without PCOS). Outcomes included the association between the plasma lipidomic profile (325 lipid species (24 classes) using liquid chromatography mass spectrometry) and PCOS, adiposity, homeostasis assessment of insulin resistance (HOMA), sex hormone-binding globulin (SHBG) and free androgen index (FAI). There were no associations of the lipidomic profile with PCOS or testosterone. HOMA was positively associated with 2 classes (dihydroceramide and triacylglycerol), SHBG was inversely associated with 2 classes (diacylglycerol and triacylglycerol), FAI was positively associated with 8 classes (ceramide, phosphatidylcholine, lysophosphatidylcholine, phosphatidylethanolamine, lysophosphatidylethanolamine, phosphatidylinositol, diacylglycerol and triacylglycerol) and waist circumference was associated with 8 classes (4 positively (dihydroceramide, phosphatidylglycerol, diacylglycerol and triacylglycerol) and 4 inversely (trihexosylceramide, GM3 ganglioside, alkenylphosphatidylcholine and alkylphosphatidylethanolamine)). The lipidomic profile was primarily related to central adiposity and FAI in women with or without PCOS. This supports prior findings that adiposity is a key driver of dyslipidaemia in PCOS and highlights the need for weight management through lifestyle interventions.Polycystic ovary syndrome (PCOS) affects up to 18% of reproductive-aged women with reproductive and metabolic complications. While lipidomics can identify associations between lipid species and metabolic diseases, no research has examined the association of lipid species with the pathophysiological features of PCOS. The aim of this study was to examine the lipidomic profile in women with and without PCOS. This study was a cross-sectional study in 156 age-matched pre-menopausal women (18-45 years, BMI >20 kg/m2; n = 92 with PCOS, n = 64 without PCOS). Outcomes included the association between the plasma lipidomic profile (325 lipid species (24 classes) using liquid chromatography mass spectrometry) and PCOS, adiposity, homeostasis assessment of insulin resistance (HOMA), sex hormone-binding globulin (SHBG) and free androgen index (FAI). There were no associations of the lipidomic profile with PCOS or testosterone. HOMA was positively associated with 2 classes (dihydroceramide and triacylglycerol), SHBG was inversely associated with 2 classes (diacylglycerol and triacylglycerol), FAI was positively associated with 8 classes (ceramide, phosphatidylcholine, lysophosphatidylcholine, phosphatidylethanolamine, lysophosphatidylethanolamine, phosphatidylinositol, diacylglycerol and triacylglycerol) and waist circumference was associated with 8 classes (4 positively (dihydroceramide, phosphatidylglycerol, diacylglycerol and triacylglycerol) and 4 inversely (trihexosylceramide, GM3 ganglioside, alkenylphosphatidylcholine and alkylphosphatidylethanolamine)). The lipidomic profile was primarily related to central adiposity and FAI in women with or without PCOS. This supports prior findings that adiposity is a key driver of dyslipidaemia in PCOS and highlights the need for weight management through lifestyle interventions.
Author Teede, H J
Moran, L J
Meikle, P J
Mundra, P A
Author_xml – sequence: 1
  givenname: L J
  surname: Moran
  fullname: Moran, L J
  email: lisa.moran@monash.edu
  organization: The Robinson Research InstituteUniversity of Adelaide, North Adelaide, South Australia, Australia
– sequence: 2
  givenname: P A
  surname: Mundra
  fullname: Mundra, P A
  organization: Metabolomics LaboratoryBaker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 3
  givenname: H J
  surname: Teede
  fullname: Teede, H J
  organization: Diabetes and Endocrine UnitMonash Health, Clayton, Victoria, Australia
– sequence: 4
  givenname: P J
  surname: Meikle
  fullname: Meikle, P J
  organization: Department of Biochemistry and Molecular BiologyUniversity of Melbourne, Melbourne, Victoria, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28500248$$D View this record in MEDLINE/PubMed
BookMark eNpNkMtLxDAQxoOsuA89eZccvVTzaNrmKMuuD1Y8uJ5Lmk7YSNvUJlX63xtxBYcPZhh-fHwzSzTrXAcIXVJyQwUnt0_Pm4TmCSGMn6AFTXOZZAXls3_zHC29fyeECpqnZ2jOChHxtFig1_0BsPLeaauCdR12Boe4amxva9dajfvBGdsA_rLhgA2oMA7gf7DeNZOefIiM-1TDhP3U1YNr4RydGtV4uDj2FXrbbvbrh2T3cv-4vtslFZdZSASVudRMGKOFkVVec5HGGwyrQDMjcxUlQGohQcQCziADmRKeZ2mmQLEVuv71jRE_RvChbK3X0DSqAzf6khZSUprxrIjo1REdqxbqsh9sGyOXf49g39rcYUk
CitedBy_id crossref_primary_10_1038_s41522_021_00231_6
crossref_primary_10_1038_s41598_019_52263_w
crossref_primary_10_1055_s_0041_1729841
crossref_primary_10_1038_s41598_025_86794_2
crossref_primary_10_1186_s13048_021_00885_y
crossref_primary_10_1210_clinem_dgab931
crossref_primary_10_1097_GCO_0000000000000410
crossref_primary_10_3389_fphys_2021_715881
crossref_primary_10_1016_j_ando_2022_07_675
crossref_primary_10_1080_00365513_2019_1658215
crossref_primary_10_1210_er_2018_00020
crossref_primary_10_1080_10408363_2024_2430775
crossref_primary_10_1371_journal_pone_0313494
crossref_primary_10_3390_ijerph17249291
crossref_primary_10_3389_fendo_2023_1077590
crossref_primary_10_1080_09513590_2021_1952976
crossref_primary_10_1111_ijpo_12734
crossref_primary_10_1002_mrd_23291
crossref_primary_10_1016_j_ejphar_2024_176742
crossref_primary_10_1016_j_tjog_2019_05_003
crossref_primary_10_1002_rmb2_12664
crossref_primary_10_1210_endrev_bnae013
crossref_primary_10_1002_dmrr_3054
crossref_primary_10_1080_09513590_2019_1698026
crossref_primary_10_1210_jendso_bvac131
crossref_primary_10_1186_s12920_021_01058_y
crossref_primary_10_3390_medicina60020244
ContentType Journal Article
Copyright 2017 Society for Endocrinology.
Copyright_xml – notice: 2017 Society for Endocrinology.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1530/JME-17-0023
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1479-6813
ExternalDocumentID 28500248
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
2WC
3O-
4.4
53G
5GY
5RE
5VS
AALGN
ABSQV
ACGFO
ACNCT
ACPRK
ADBBV
ADDZX
ADMOG
AENEX
AFFNX
AFHIN
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
F9R
FRP
GX1
H13
HZ~
IL9
INIJC
KQ8
L7B
NPM
O9-
OK1
P2P
REN
TBS
TR2
W2D
W8F
WOQ
X7M
ZGI
ZXP
7X8
ID FETCH-LOGICAL-b396t-51979c25ffc5f9b7d354023f2bec2f97a97a5e9c59e5555e32e6e94037646aea2
IEDL.DBID 7X8
ISICitedReferencesCount 32
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000405290500013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1479-6813
IngestDate Thu Oct 02 06:04:57 EDT 2025
Mon Mar 10 13:11:07 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords hyperandrogenism
insulin resistance
lipidomics
obesity
polycystic ovary syndrome
Language English
License 2017 Society for Endocrinology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b396t-51979c25ffc5f9b7d354023f2bec2f97a97a5e9c59e5555e32e6e94037646aea2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://jme.bioscientifica.com/downloadpdf/journals/jme/59/1/93.pdf
PMID 28500248
PQID 1899116368
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1899116368
pubmed_primary_28500248
PublicationCentury 2000
PublicationDate 2017-07-01
PublicationDateYYYYMMDD 2017-07-01
PublicationDate_xml – month: 07
  year: 2017
  text: 2017-07-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of molecular endocrinology
PublicationTitleAlternate J Mol Endocrinol
PublicationYear 2017
SSID ssj0015174
Score 2.3389685
Snippet Polycystic ovary syndrome (PCOS) affects up to 18% of reproductive-aged women with reproductive and metabolic complications. While lipidomics can identify...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 93
SubjectTerms Adult
Blood Glucose - metabolism
Ceramides - blood
Ceramides - classification
Cross-Sectional Studies
Dyslipidemias - blood
Dyslipidemias - diagnosis
Dyslipidemias - pathology
Female
Gangliosides - blood
Gangliosides - classification
Glycerophospholipids - blood
Glycerophospholipids - classification
Humans
Insulin - blood
Insulin Resistance
Lipid Metabolism
Metabolome
Middle Aged
Obesity - blood
Obesity - diagnosis
Obesity - pathology
Polycystic Ovary Syndrome - blood
Polycystic Ovary Syndrome - diagnosis
Polycystic Ovary Syndrome - pathology
Premenopause - physiology
Sex Hormone-Binding Globulin - metabolism
Testosterone - blood
Triglycerides - blood
Triglycerides - classification
Title The association of the lipidomic profile with features of polycystic ovary syndrome
URI https://www.ncbi.nlm.nih.gov/pubmed/28500248
https://www.proquest.com/docview/1899116368
Volume 59
WOSCitedRecordID wos000405290500013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qRHzxsnmZNyKIb2FLekueRGRDxI2BCnsraZrAYLZ1nYP-e0_ajD0JgqX0qYVDzum5n-8gdKcoA_oiQWjqMeJLFRLJEkrA1U45BGNh2HD6NRqP-XQqJi7hVrq2yrVOrBV1miubI-9RCAwoOA8hfyi-iN0aZaurboXGNmp54MpYqY6mmyqCQ2GmPtAScuq5-bzA6_deRgMC-tmarN99y9rGDA__S90ROnDeJX5sxOEYbemsjTqPGUTWnxW-x3W_Z51Ib6O9kSurd9AbCAuWG0bh3GBwDPF8VsxSO7aM3WpvbNO22OgaDbS0rxX5vFKVBXvG-UouKryGQDhBH8PB-9MzcdsWSOKJcEnsBKtQLDBGBUYkUWozQswzDLjMjIgk3IEWKhA6gEt7TIda-H3QUH4otWSnaCfLM32OcKC59BVYfsWZH3EpE6UTnvp-JBVNqddFt-tTjEGabYlCZjr_LuPNOXbRWcOKuGhgN2LGgxqB7eIPX1-ifWbtb91Xe4VaBv5lfY121Wo5Kxc3tZjAczwZ_QDjwMgT
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+association+of+the+lipidomic+profile+with+features+of+polycystic+ovary+syndrome&rft.jtitle=Journal+of+molecular+endocrinology&rft.au=Moran%2C+L+J&rft.au=Mundra%2C+P+A&rft.au=Teede%2C+H+J&rft.au=Meikle%2C+P+J&rft.date=2017-07-01&rft.eissn=1479-6813&rft.volume=59&rft.issue=1&rft.spage=93&rft_id=info:doi/10.1530%2FJME-17-0023&rft_id=info%3Apmid%2F28500248&rft_id=info%3Apmid%2F28500248&rft.externalDocID=28500248
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-6813&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-6813&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-6813&client=summon